By
Diagnostics firms should still get fair valuation in IPOs: Thyrocare’s Velumani
Arokiaswamy Velumani

Thyrocare Technologies Ltd had made a spectacular debut on the stock exchanges two years ago. But its share prices have fallen...

TO READ THE FULL STORY


Leave Your Comment(s)